Uruguay Observes National Multiple Sclerosis Day Amid Growing Concerns

Uruguay marks National Multiple Sclerosis Day, highlighting the growing concern of MS, which affects around 800 people in the country. A new assistive technology, the Neural Sleeve, has shown promising results in improving mobility for MS patients.

author-image
Nitish Verma
New Update
Uruguay Observes National Multiple Sclerosis Day Amid Growing Concerns

Uruguay Observes National Multiple Sclerosis Day Amid Growing Concerns

On May 29, Uruguay observes National Multiple Sclerosis Day, highlighting the challenges faced by those living with this chronic autoimmune disease. Multiple sclerosis (MS) primarily affects women and has become an increasing concern in the country.

According to recent statistics, approximately 800 people in Uruguay are diagnosed with MS, and around 80 new cases are reported each year. This steady increase highlights the need for heightened awareness and improved medical support for those affected.

MS is a chronic autoimmune condition that impacts the central nervous system, leading to symptoms such as fatigue, difficulty walking, numbness, and vision problems. The disease's unpredictable nature and progressive course make it particularly challenging for patients and healthcare providers.

In recent developments, California-based bionic clothing firm Cionic has introduced the Neural Sleeve, an assistive technology designed to enhance mobility for MS patients. A study published in the International Journal of MS Care has shown that the Neural Sleeve significantly improves ankle kinematics during gait, addressing issues like decreased dorsiflexion and increased inversion.

Raising awareness about Multiple Sclerosis is vital for improving the quality of life for those affected and driving research towards a cure. The disease's continued impact on a growing number of people, particularly women, makes it crucial that we address the mounting concern and provide adequate medical support to mitigate its effects.

Jeremiah Robison, CEO of Cionic, commented on the study's findings, stating, "These results show the tremendous power of our software-steered neuromodulation array and real-time adaptive algorithms to improve walking for individuals with MS." The promising results have led to further investment, with Cionic raising $12 million in a Series A extension financing round to advance the Neural Sleeve's development.

Doug Wadja, the lead author of the study, added, "Our findings highlight the efficacy of a comprehensive technology that can address a wider variety of gait impairments at once. It's encouraging that all participants experienced improvements to two of the key measures that impact safe walking."

As Uruguay continues to mark National Multiple Sclerosis Day, the focus remains on raising awareness, supporting research, and improving the quality of life for those affected by MS. The introduction of innovative technologies like the Neural Sleeve offers hope and highlights the importance of ongoing advancements in MS care.

Key Takeaways

  • Uruguay observes National Multiple Sclerosis Day on May 29.
  • Approximately 800 people in Uruguay have MS, with 80 new cases reported annually.
  • MS is a chronic autoimmune disease affecting the central nervous system.
  • Cionic's Neural Sleeve improves mobility for MS patients by enhancing ankle kinematics.
  • $12 million invested in Neural Sleeve's development to advance MS care.